Search results for

In 1939, the character of Mr. Smith — played by Jimmy Stewart — spent 25 hours on the Senate floor railing against corruption.

President Trump's rival advisors Peter Navarro and Elon Musk are in a war of words over whether Tesla relies on imported parts. Musk has the facts on his side.

Playboi Carti's supersized blockbuster MUSIC holds at No. 1 in its second week of release. Elsewhere, Kendrick Lamar's "Luther (feat. SZA)" holds at No. 1and Morgan Wallen charts a fifth top 10 hit from an album that isn't even out yet.

Through an email blast, federal workers were given the opportunity to resign from their jobs before Feb. 6 and retain full pay and benefits through Sept. 30.

Angeline Murimirwa, whose parents couldn't afford school fees, is on Time magazine's "most influential" list — recognizing her work as CEO of Camfed, a charity giving girls a chance for an education.

Cam Ward went from zero-star recruit to No. 1 pick in the NFL draft, and the Jacksonville Jaguars paid a ton use Cleveland's pick on Travis Hunter at No. 2. Colorado star Shedeur Sanders wasn't taken in the first round.

The former Hollywood producer is on trial for sex crimes in New York — again. Here are the allegations and proceedings that have led to this.

The Netflix series follows a 13-year-old accused of murdering a girl from his school. Co-creator and star Stephen Graham says he read about similar crimes and wanted to know: "Why is this happening?"

President Trump's administration has fired more than 20,000 federal workers. How does the federal workforce compare with those of other countries?

Unions and attorneys who represent federal employees are telling workers not to take the offer from the Trump administration to resign from their jobs by Feb. 6 and still be paid through September.

The Six Triple Eight sorted millions of pieces of wartime mail in a matter of months but weren't recognized publicly for decades. Just two of the 855 women are believed to be alive for the ceremony.

Health care price transparency is one of the few bipartisan issues in Washington, D.C. But much of the information is not helpful to patients, and there's no evidence that it's lowering costs.